Evidence map›Paper›PMID 40217550›Full record

ReviewActa epileptologica2023

Arterial spin labeling perfusion MRI applications in drug-resistant epilepsy and epileptic emergency.

Yingchun Xu, Ge Tan, Deng Chen, Jiao Liu, Zixian Zhou, Ling Liu

Abstract readReview
In one paragraph

Review in Acta epileptologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yingchun XuDepartment Neurology, Sichuan University, West China Hospital, Guo Xue Lane 37, Chengdu, 610041, Sichuan, PR China.
Ge TanDepartment Neurology, Sichuan University, West China Hospital, Guo Xue Lane 37, Chengdu, 610041, Sichuan, PR China.
Deng ChenDepartment Neurology, Sichuan University, West China Hospital, Guo Xue Lane 37, Chengdu, 610041, Sichuan, PR China.
Jiao LiuDepartment Neurology, Sichuan University, West China Hospital, Guo Xue Lane 37, Chengdu, 610041, Sichuan, PR China.
Zixian ZhouDepartment Neurology, Sichuan University, West China Hospital, Guo Xue Lane 37, Chengdu, 610041, Sichuan, PR China.
Ling LiuDepartment Neurology, Sichuan University, West China Hospital, Guo Xue Lane 37, Chengdu, 610041, Sichuan, PR China. neurologyliuling@163.com.ORCID http://orcid.org/0000-0001-7588-6086

Funding

Health Commission of Sichuan Province 20ZD005Sichuan Province Science and Technology Support Program 2021YFS0174
6 · The paper itself

Abstract

Epilepsy affects all age groups and is one of the most common and disabling neurological disorders worldwide. Drug-resistant epilepsy (DRE), status epilepticus (SE), and sudden unexpected death in epilepsy (SUDEP), which are associated with considerable healthcare costs and mortality, have always been difficult to address and become the focus of clinical research. The rapid identification of seizure onset and accurate localization of epileptic foci are crucial for the treatment and prognosis of people with DRE, SE, or near-SUDEP. However, most of the conventional neuroimaging techniques for assessing cerebral blood flow of people with epilepsy are restricted by time consumption, limited resolution, and ionizing radiation. Arterial spin labeling (ASL) is a newly powerful non-contrast magnetic resonance imaging technique that enables the quantitative evaluation of brain perfusion, characterized by its unique advantages of reproducibility and easy accessibility. Recent studies have demonstrated the potential advantages of ASL for the diagnosis and evaluation of epilepsy. Therefore, in this review, we discussed the complementary value of ASL in evaluating and characterizing the basic substrates underlying refractory epilepsy and epileptic emergencies.

Indexed as

Arterial spin labelingCerebral blood flowDrug-resistant epilepsyEpileptic emergencyStatus epilepticusSUDEP

Identifiers

PMID40217550
PMCPMC11960231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.